Modulation des Mikrobioms

Maria Vehreschild; Stefanie Gräfe

doi:10.1055/a-0973-6171

Krankenhaushygiene up2date, Table of Contents

Krankenhaushygiene up2date 2020; 15(01): 87-99
DOI: 10.1055/a-0973-6171

Varia

Modulation des Mikrobioms

Maria Vehreschild

,

Stefanie Gräfe

Subject Editor: Wissenschaftlich verantwortlich gemäß Zertifizierungsbestimmungen für diesen Beitrag ist Prof. Dr. Sebastian Lemmen, Aachen.

Abstract

All articles of this category

Der Einfluss der uns kolonisierenden Mikroorganismen, der sog. Mikrobiota, auf unseren Körper ist mittlerweile unumstritten. Diverse Krankheitsbilder stehen in Verbindung mit der Zusammensetzung unseres Mikrobioms. Dessen Veränderungen können Ursache einer Erkrankung, Therapiefolge oder unabhängig davon auftreten. Daher ist die gezielte Modulation der Mikrobiota ein vielversprechender Ansatz in der Prävention sowie Therapie vieler Krankheiten.

Full Text

References

Literatur
1 Ohland CL, Jobin C. Microbial activities and intestinal homeostasis: A delicate balance between health and disease. Cell Mol Gastroenterol Hepatol 2015; 1: 28-40
2 Kennedy AD, Wittmann BM, Evans AM. et al. Metabolomics in the clinic: A review of the shared and unique features of untargeted metabolomics for clinical research and clinical testing. Journal of mass spectrometry: JMS 2018; 53: 1143-1154
3 Smirnov KS, Maier TV, Walker A. et al. Challenges of metabolomics in human gut microbiota research. International journal of medical microbiology: IJMM 2016; 306: 266-279
4 Marchesi JR, Adams DH, Fava F. et al. The gut microbiota and host health: a new clinical frontier. Gut 2016; 65: 330-339
5 Kashyap PC, Chia N, Nelson H. et al. Microbiome at the Frontier of Personalized Medicine. Mayo Clinic Proceedings 2017; 92: 1855-1864
6 Dang AT, Marsland BJ. Microbes, metabolites, and the gut–lung axis. Mucosal Immunology 2019; 12: 843-850
7 Quigley EMM. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Current neurology and neuroscience reports 2017; 17: 94
8 Wiest R, Albillos A, Trauner M. et al. Targeting the gut-liver axis in liver disease. Journal of hepatology 2017; 67: 1084-1103
9 Holster S, Lindqvist CM, Repsilber D. et al. The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study. Clinical and translational gastroenterology 2019; 10: e00034
10 Hagel S, Fischer A, Ehlermann P. et al. Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile Infection. Deutsches Ärzteblatt international 2016; 113: 583-589
11 Khan MY, Dirweesh A, Khurshid T. et al. Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis. European journal of gastroenterology & hepatology 2018; 30: 1309-1317
12 Dubberke ER, Mullane KM, Gerding DN. et al. Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile Infection. Open forum infectious diseases 2016; 3: ofw133
13 Cammarota G, Ianiro G, Kelly CR. et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice. Gut 2019; 68: 2111-2121
14 Upadhyaya B, McCormack L, Fardin-Kia AR. et al. Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions. Scientific reports 2016; 6: 28797-28797
15 Petrof EO, Khoruts A. From Stool Transplants to Next-Generation Microbiota Therapeutics. Gastroenterology 2014; 146: 1573-1582
16 Carlucci C, Jones CS, Oliphant K. et al. Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile. Scientific reports 2019; 9: 885
17 Chase D, Goulder A, Zenhausern F. et al. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecologic oncology 2015; 138: 190-200
18 DeLong K, Bensouda S, Zulfiqar F. et al. Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant. Frontiers in cellular and infection microbiology 2019; 9: 306
19 Garcia-Velasco JA, Menabrito M, Catalan IB. What fertility specialists should know about the vaginal microbiome: a review. Reproductive biomedicine online 2017; 35: 103-112
20 Stapleton AE. The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr 2016; 4
21 Dominguez-Bello MG, De Jesus-Laboy KM, Shen N. et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nature medicine 2016; 22: 250-253
22 Kundu P, Blacher E, Elinav E. et al. Our Gut Microbiome: The Evolving Inner Self. Cell 2017; 171: 1481-1493
23 Komesu YM, Dinwiddie DL, Richter HE. et al. Defining the Relationship Between Vaginal and Urinary Microbiomes. American journal of obstetrics and gynecology 2019;
24 Whiteside SA, Razvi H, Dave S. et al. The microbiome of the urinary tract – a role beyond infection. Nature reviews Urology 2015; 12: 81-90
25 Hill C, Guarner F, Reid G. et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews Gastroenterology & hepatology 2014; 11: 506-514
26 Rondanelli M, Faliva MA, Perna S. et al. Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. Gut Microbes 2017; 8: 521-543
27 Sanders ME, Merenstein DJ, Reid G. et al. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nature Reviews Gastroenterology & Hepatology 2019;
28 Maldonado-Gomez MX, Martinez I, Bottacini F. et al. Stable Engraftment of Bifidobacterium longum AH1206 in the Human Gut Depends on Individualized Features of the Resident Microbiome. Cell host & microbe 2016; 20: 515-526
29 Thomas DW, Greer FR. Probiotics and prebiotics in pediatrics. Pediatrics 2010; 126: 1217-1231
30 Scaldaferri F, Gerardi V, Mangiola F. et al. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update. World journal of gastroenterology 2016; 22: 5505-5511
31 Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). Fäkale Mikrobiota-Transplantation (FMT, Stuhltransplantation): Risiko für die Übertragung von multiresistenten Erregern. Im Internet: (Stand: 14.02.2020) www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RI/2019/RI-FMT.html
32 Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL). Nahrungsergänzungsmittel vs. Arzneimittel. Im Internet: (Stand: 14.02.2020) www.bvl.bund.de/DE/01_Lebensmittel/03_Verbraucher/04_NEM/01_NEM_Arzneimittel/NEM_Arzneimittel_node.html
33 Doron S, Snydman DR. Risk and safety of probiotics. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015; 60 (Suppl. 02) S129-134
34 Suez J, Zmora N, Zilberman-Schapira G. et al. Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell 2018; 174: 1406-1423.e1416
35 Platsidaki E, Dessinioti C. Recent advances in understanding Propionibacterium acnes (Cutibacterium acnes) in acne. F1000Research 2018; 7
36 Egert M, Simmering R, Riedel CU. The Association of the Skin Microbiota With Health, Immunity, and Disease. Clinical pharmacology and therapeutics 2017; 102: 62-69
37 Myles IA, Earland NJ, Anderson ED. et al. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight 2018; 3: e120608
38 Knackstedt R, Knackstedt T, Gatherwright J. The role of topical probiotics on skin conditions: A systematic review of animal and human studies and implications for future therapies. Experimental dermatology 2019;
39 Elison E, Vigsnaes LK, Rindom Krogsgaard L. et al. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr 2016; 116: 1356-1368
40 Maier TV, Lucio M, Lee LH. et al. Impact of Dietary Resistant Starch on the Human Gut Microbiome, Metaproteome, and Metabolome. MBio 2017; 8
41 Baxter NT, Schmidt AW, Venkataraman A. et al. Dynamics of Human Gut Microbiota and Short-Chain Fatty Acids in Response to Dietary Interventions with Three Fermentable Fibers. MBio 2019; 10: e02566-02518
42 Costantini L, Molinari R, Farinon B. et al. Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int J Mol Sci 2017; 18: 2645
43 Winston JA, Theriot CM. Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract. Anaerobe 2016; 41: 44-50